
### [NCIT:C43527](http://purl.obolibrary.org/obo/NCIT_C43527)
**Label:** Sporadic Gastric Adenocarcinoma

**Subclasses:** [NCIT:C27131](http://purl.obolibrary.org/obo/NCIT_C27131) (Early Gastric Cancer), [NCIT:C5248](http://purl.obolibrary.org/obo/NCIT_C5248) (Mucinous Gastric Adenocarcinoma), [NCIT:C5473](http://purl.obolibrary.org/obo/NCIT_C5473) (Gastric Tubular Adenocarcinoma), [NCIT:C95763](http://purl.obolibrary.org/obo/NCIT_C95763) (Gastric Intramucosal Adenocarcinoma), [NCIT:C27765](http://purl.obolibrary.org/obo/NCIT_C27765) (Helicobacter Pylori-Related Gastric Adenocarcinoma), [NCIT:C5250](http://purl.obolibrary.org/obo/NCIT_C5250) (Signet Ring Cell Gastric Adenocarcinoma), [NCIT:C9157](http://purl.obolibrary.org/obo/NCIT_C9157) (Gastric Intestinal-Type Adenocarcinoma), [NCIT:C5472](http://purl.obolibrary.org/obo/NCIT_C5472) (Gastric Papillary Adenocarcinoma), [NCIT:C67526](http://purl.obolibrary.org/obo/NCIT_C67526) (Gastric Mixed Adenocarcinoma), [NCIT:C95748](http://purl.obolibrary.org/obo/NCIT_C95748) (Gastric Carcinoma with Lymphoid Stroma), [NCIT:C95747](http://purl.obolibrary.org/obo/NCIT_C95747) (Gastric Hepatoid Adenocarcinoma), [NCIT:C43529](http://purl.obolibrary.org/obo/NCIT_C43529) (Sporadic Diffuse Gastric Adenocarcinoma), [NCIT:C95743](http://purl.obolibrary.org/obo/NCIT_C95743) (Poorly Cohesive Gastric Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40363](http://purl.obolibrary.org/obo/NCIT_C40363) (Nipple Syringomatous Adenoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40362](http://purl.obolibrary.org/obo/NCIT_C40362) (Low Grade Adenosquamous Breast Carcinoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40358](http://purl.obolibrary.org/obo/NCIT_C40358) (Squamous Cell Breast Carcinoma, Spindle Cell Variant))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40356](http://purl.obolibrary.org/obo/NCIT_C40356) (Breast Large Cell Neuroendocrine Carcinoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40355](http://purl.obolibrary.org/obo/NCIT_C40355) (Breast Columnar Cell Mucinous Carcinoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40354](http://purl.obolibrary.org/obo/NCIT_C40354) (Breast Mucinous Cystadenocarcinoma))) 37.02%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40350](http://purl.obolibrary.org/obo/NCIT_C40350) (Breast Carcinoma with Choriocarcinomatous Features))) 37.02%


